AHR antagonist 4

AHR antagonist 4 is a 2-heteroaryl-3-oxo-2,3-dihydropyridazine-4-carboxamide compound and a potent aryl hydrocarbon receptor (AHR) antagonist extracted from patent WO2018146010A1, example 293, has an IC50 of 82.2 nM. AHR antagonist 4 has anti-cancer effects[1].

Product Specifications

CAS Number

[2242465-58-1]

UNSPSC

12352005

Target

Aryl Hydrocarbon Receptor

Type

Reference compound

Related Pathways

Immunology/Inflammation

Applications

Cancer-programmed cell death

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/ahr-antagonist-4.html

Solubility

10 mM in DMSO

Smiles

O=C(C1=CC(C2=CC=C(OC(F)(F)F)C=C2)=NN(C3=CC=CN=C3)C1=O)NC[C@H](O)C(F)(F)F

Molecular Formula

C20H14F6N4O4

Molecular Weight

488.34

References & Citations

[1]Ilona GUTCHER, et al. 2-heteroaryl-3-oxo-2,3-dihydropyridazine-4-carboxamides for the treatment of cancer. WO2018146010A1.

Shipping Conditions

Room temperature

Scientific Category

Reference compound1

Clinical Information

No Development Reported

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

MBS9211060-01 0.08 mL

BMPR1B Antibody (C-term)

Ask

View Details

MBS9211060-02 0.4 mL

BMPR1B Antibody (C-term)

Ask

View Details

MBS9211060-03 5x 0.4 mL

BMPR1B Antibody (C-term)

Ask

View Details

MR218185L4V 200 µL

Cacng3 (NM_019430) Mouse Tagged ORF Clone Lentiviral Particle

Ask

View Details

E-AB-F1104UD-01 25 µg

PE Anti-Mouse CD8a Antibody[53-6.7]

Ask

View Details

E-AB-F1104UD-02 100 µg

PE Anti-Mouse CD8a Antibody[53-6.7]

Ask

View Details